ENO2 and lymphangioma: In this study, we intend to analyze the CSF and serum CEACAM6 level in LUAD‐LM patients, compared to traditional biomarkers like CEA, cytokeratin 19 fragment (CYFRA 21‐1) and neuron‐specific enolase (NSE).